Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice

mBio(2024)10.1128/mbio.00186-24Source: DataRank Database

LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.40)OA: goldTopics (100)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Richard A. Bowen ORCID,P. Back ORCID,Saša Masleša-Galić ORCID,Susana Nava,Marcus A. Horwitz ORCID

Live enrichment

PubMed:38511933 OpenAlex:https://openalex.org/W4393040392

HHS | National Institutes of Health

Grant: AI141390

National Institutes of Health

Grant: 3P30CA016042-35S3

Cancer Center Support Grant

National Institutes of Health

Grant: 5P30AI028697-26

Biostatistics Core

National Institutes of Health

Grant: 5R01AI141390-03

Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform

FWCI

1.40

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00186-24

publisherhttps://doi.org/10.1128/mbio.00186-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.00186-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38511933

repositoryhttps://escholarship.org/uc/item/554007tk

Fields of Study

Burkholderia infections and melioidosisBrucella: diagnosis, epidemiology, treatment0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsAnthraxAntigens, BacterialBacterial VaccinesHumansMelioidosisMice, Inbred BALB CPlagueTularemiaVaccines, AttenuatedBurkholderia pseudomalleiMice

Keywords

MelioidosisBurkholderia pseudomalleiBiologyMicrobiologyVirologyNasal administrationAnthrax vaccinesAntigenImmunizationImmunologyBacteriaPrevention (rcdc)LVS ΔcapBLung (rcdc)LVS Delta capBMice0605 Microbiology (for)vaccineAnimals (mesh)Immunization (rcdc)32 Biomedical and Clinical Sciences (for-2020)3101 Biochemistry and cell biology (for-2020)LungTularemiaInbred BALB CHumans (mesh)Bacterial Vaccines (mesh)VaccinesMice, Inbred BALB C3 Good Health and Well Being (sdg)3107 Microbiology (for-2020)BacterialMice (mesh)Anthrax (mesh)Bacterial (mesh)QR1-502Infection (hrcs-hc)Infectious Diseases3.4 VaccinesMedical Microbiology5.1 PharmaceuticalsVaccine Related (rcdc)Melioidosis (mesh)Plague (mesh)select agentBacterial VaccinesInfectionBiotechnologyResearch Article570Inbred BALB C (mesh)610Biotechnology (rcdc)Vaccines, AttenuatedBurkholderia pseudomallei (mesh)Emerging Infectious Diseases (rcdc)Vaccine RelatedRare Diseases (rcdc)AnthraxRare Diseases5.1 Pharmaceuticals (hrcs-rac)BiodefenseHumansAnimals3207 Medical Microbiology (for-2020)Biodefense (rcdc)AntigensAttenuated (mesh)live attenuated vaccinePlagueAntigens, BacterialBiomedical and Clinical SciencesPreventionVector-Borne Diseases (rcdc)3.4 Vaccines (hrcs-rac)Tularemia (mesh)Vector-Borne DiseasesEmerging Infectious DiseasesOrphan DrugGood Health and Well BeingAttenuatedInfectious Diseases (rcdc)Biochemistry and cell biologyOrphan Drug (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being